Skip to main content
Clinical Trials/CTRI/2023/03/050428
CTRI/2023/03/050428
Recruiting
Phase 3

Comparative evaluation of efficacy of healingeffect of topical Jayanti (Tridaxprocumbens)cream vs topical lignocaine & Nifedipine creamin Parikartika (Acute fissure-in-ano).

Datta Meghe Institute Of Higher Education And Research0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K600- Acute anal fissure
Sponsor
Datta Meghe Institute Of Higher Education And Research
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Datta Meghe Institute Of Higher Education And Research

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with age group of 20 yrs to 50 yrs.
  • 2\. Patients with clinical features of Acute fissure\-in\-ano \<6 weeks will be included after screening
  • irrespective of age, sex, religion and socioeconomic status.
  • 3\. Patients with grade 0 and 1 anal spasm.
  • 4\. Controlled cases of Diabetes mellitus (RBS \>200 mg/dl upto 300mg/dl) Acute fissure\-in\-ano \<6 weeks.
  • 5\. Known cases with immune\-compromised status i.e Tuberculosis, HIV, Hepatitis B and sexually
  • transmitted diseases on standard medication with Acute fissure\-in\-ano \< 6 weeks.

Exclusion Criteria

  • 1\. Chronic patients \> 6 weeks with sentinel tag.
  • 2\. Patients with grade 2 anal spasm.
  • 3\. Patients suffering with Haemorrhoids, Fistula\-in\-ano, Carcinoma Rectum and associated anorectal
  • 4\. Patients suffering with systemic disorder like Uncontrolled Diabetes mellitus.
  • 5\. Known cases of Anaemia, Bleeding crises, Anorectal Malignancy, Crohn’s disease, Ulcerative colitis will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials